| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S004320050296 |
| P698 | PubMed publication ID | 10394963 |
| P2093 | author name string | Z Y Tang | |
| X M Li | |||
| Y N Zhou | |||
| H C Sun | |||
| Z C Ma | |||
| B R Sun | |||
| P433 | issue | 7 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| microvessel | Q6840468 | ||
| P304 | page(s) | 419-426 | |
| P577 | publication date | 1999-07-01 | |
| P1433 | published in | Journal of Cancer Research and Clinical Oncology | Q2081599 |
| P1476 | title | Microvessel density of hepatocellular carcinoma: its relationship with prognosis | |
| P478 | volume | 125 |
| Q35611503 | A decade's studies on metastasis of hepatocellular carcinoma |
| Q38930303 | A polysaccharide from mushroom Huaier retards human hepatocellular carcinoma growth, angiogenesis, and metastasis in nude mice |
| Q35701281 | Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives |
| Q41947562 | Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization |
| Q64116505 | Angiogenesis of hepatocellular carcinoma: An immunohistochemistry study |
| Q83968175 | CEACAM1 cytoplastic expression is closely related to tumor angiogenesis and poorer relapse-free survival after curative resection of hepatocellular carcinoma |
| Q51606004 | Cancer Patient-Derived Circulating Microparticles Enhance Lung Metastasis in a Rat Model: Dual-Source CT, Cellular, and Molecular Studies. |
| Q35165648 | Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches |
| Q34382605 | Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma |
| Q37122823 | Diagnostic value of immunohistochemical staining of GP73, GPC3, DCP, CD34, CD31, and reticulin staining in hepatocellular carcinoma. |
| Q53397248 | Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study. |
| Q53167550 | Esophageal squamous cell carcinoma: assessing tumor angiogenesis using multi-slice CT perfusion imaging. |
| Q40557819 | Establishment of green fluorescent protein-expressing hepatocellular carcinoma cell lines with different metastatic potential: relevant models for in vivo monitoring of metastasis and angiogenesis |
| Q36190339 | Expression of MUC1 and its significance in hepatocellular and cholangiocarcinoma tissue |
| Q37565073 | FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis |
| Q34512068 | Hepatocellular carcinoma--cause, treatment and metastasis |
| Q33843943 | Hepatocellular carcinomas in cirrhotic and noncirrhotic human livers share angiogenic characteristics |
| Q39411944 | High co-expression of vascular endothelial growth factor receptor-1 and Snail is associated with poor prognosis after curative resection of hepatocellular carcinoma |
| Q34139199 | High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients |
| Q34937019 | Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer. |
| Q54453776 | Liver cancer: Regorafenib as second-line therapy in hepatocellular carcinoma. |
| Q41921063 | Lymphatic vessel endothelial hyaluronan receptor-1 is a novel prognostic indicator for human hepatocellular carcinoma |
| Q30378880 | Malignant focal liver lesions at contrast-enhanced ultrasonography and magnetic resonance with hepatospecific contrast agent. |
| Q48355658 | Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice |
| Q36523877 | Mesenchymal stem cells promote tumor angiogenesis via the action of transforming growth factor β1. |
| Q37281023 | Microvessel density and clinicopathologic characteristics in hepatocellular carcinoma with and without cirrhosis. |
| Q36065951 | Microvessel density of malignant and benign hepatic lesions and MRI evaluation |
| Q26824035 | Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis |
| Q46161399 | Novel endothelial cell markers in hepatocellular carcinoma |
| Q38808028 | Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma. |
| Q37088265 | Predictive biomarkers of antiangiogenic therapy for advanced hepatocellular carcinoma: where are we? |
| Q47251274 | Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer |
| Q34758849 | Prognostic roles of cross-talk between peritumoral hepatocytes and stromal cells in hepatocellular carcinoma involving peritumoral VEGF-C, VEGFR-1 and VEGFR-3. |
| Q54782190 | Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival. |
| Q35810123 | Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature |
| Q37301807 | Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma |
| Q37338042 | Relationship between microvessel count and post-hepatectomy survival in patients with hepatocellular carcinoma |
| Q44285847 | Study on the changes in microvessel density in hepatocellular carcinoma following transcatheter arterial chemoembolization |
| Q45387961 | The angiogenic and prognostic implications of VEGF, Ang-1, Ang-2, and MMP-9 for hepatocellular carcinoma with background of hepatitis B virus |
| Q47654336 | The association between aquaporin-1 expression, microvessel density and the clinicopathological features of hepatocellular carcinoma |
| Q33977116 | The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib |
| Q84757395 | The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas |
| Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
| Q37274051 | Three-dimensional Contrast-enhanced Ultrasound in Response Assessment for Breast Cancer: A Comparison with Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathology |
| Q47616016 | Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses |
Search more.